Safety and immunogenicity of a recombinant HIV type 1 glycoprotein 160 boosted by a V3 synthetic peptide in HIV-negative volunteers

Authors :: Salmonceron, D.
Excler, J.L.
Sicard, D.
Blanche, P.
Finkielstzjien, L.
Gluckman, J.C.
Autran, B.
Matthews, T.J.
Meignier, B.
Kieny, M.P.
Valentin, C.
Gonnet, P.
Diaz, I.
Salomon, H.
Pialoux, G.
Gonzalezcanali, G.
Plotkin, S.
Source :: AIDS Weekly. Feb 19, 1996, p57, 2 p.
Publication Year :: 1996
Abstract: According to the authors' abstract of an article published in AIDS Research and Human Retroviruses, "The safety and the immunogenicity of a recombinant hybrid envelope glycoprotein MN/LAI (rgp160) followed by [...]

Subjects :: AIDS vaccines -- Research
HIV antibodies -- Measurement
Glycoproteins -- Physiological aspects
T cell proliferation -- Measurement

Tools